Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A membrane-associated MHC-I inhibitory axis for cancer immune evasion

Cell(2023)10.1016/j.cell.2023.07.016Source: DataRank Database

A membrane-associated MHC-I inhibitory axis for cancer immune evasion is a research paper published in Cell (2023). On theSindex it has a DataRank of 0. It has been cited 194 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access194 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (17 grants)OA: greenTopics (26)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (25)

Lu Qiao ORCID,Hua Zhou ORCID,Jia Liu ORCID,Bettina Nadorp ORCID,Audrey Lasry ORCID

Live enrichment

PubMed:37557169

NCI NIH HHS

Grant: R01 CA173636

NCATS NIH HHS

Grant: UM1 TR004538

NCRR NIH HHS

Grant: UL1 RR025767

NCI NIH HHS

Grant: R01 CA266212

NCI NIH HHS

Grant: R01 CA216421

NHLBI NIH HHS

Grant: R01 HL159175

NCI NIH HHS

Grant: R01 CA242020

NCI NIH HHS

Grant: R01 CA269898

NCI NIH HHS

Grant: R01 CA264248

NCI NIH HHS

Grant: P30 CA016087

NIAID NIH HHS

Grant: R21 AI163924

NIGMS NIH HHS

Grant: R35 GM136250

NIGMS NIH HHS

Grant: R01 GM114102

NCI NIH HHS

Grant: R01 CA228135

NCI NIH HHS

Grant: R37 CA273333

NCI NIH HHS

Grant: R01 CA283574

Howard Hughes Medical Institute

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10961051/pdf/nihms-1965866.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0092867423007833?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0092867423007833?httpAccept=text/plain

Fields of Study

HumansAntigen PresentationCD8-Positive T-LymphocytesHistocompatibility Antigens Class IHLA AntigensNeoplasmsUbiquitin-Protein LigasesTumor Escape

MeSH Terms

HumansAntigen PresentationCD8-Positive T-LymphocytesHistocompatibility Antigens Class IHLA AntigensNeoplasmsUbiquitin-Protein LigasesTumor Escape

Keywords

MHC-ISUSD6T cellTMEM127WWP2antigen presentationcancerimmune evasionlysosomal degradationubiquitination

Related Papers (3)

GM-CSF: A Double-Edged Sword in Cancer Immunotherapy

N/A

0.836DataRank · unranked

Frontiers in Immunology(2022)

co-cited

10.3389/fimmu.2022.901277

The feasibility of using an autologous GM-CSF-secreting breast cancer vaccine to induce immunity in patients with stage II–III and metastatic breast cancers

N/A

0.750DataRank · unranked

Breast Cancer Research and Treatment(2022)

co-cited

10.1007/s10549-022-06562-y

Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer

Nature(2023)

co-cited

10.1038/s41586-023-06063-y